Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pediatric Rheumatology Online Journal|February 24, 2023
Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature reviewGerd Horneff, Kirsten Minden, Catherine Rolland, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|August 23, 2007
Subjective global assessment in the clinical settingFernando Baccaro, Jose Balza Moreno, Cecilia Borlenghi, et al.
Dermatology and Therapy|November 23, 2023
Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with PsoriasisPaula C Luna, Chia-Yu Chu, Mohammad Fatani, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|July 31, 2018
Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?Valderilio Feijó Azevedo, Alejandra Babini, Carlo V Caballero-Uribe, et al.
Dermatology Online Journal|March 23, 2017
Psoriasis in Latin AmericaEdgardo Chouela, Mario Amaya, Angela Londoño, et al.
Drugs & Aging|July 12, 2019
Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled TrialsChristopher J Edwards, Katherine Roshak, Jack F Bukowski, et al.
Open Access Rheumatology : Research and Reviews|December 19, 2019
Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid ArthritisGeneroso Guerra Bautista, Ricardo Machado Xavier, Maria de la Vega, et al.
Advances in Rheumatology (London, England)|September 9, 2021
Predictors of response to etanercept-methotrexate treatment: a post hoc logistic regression analysis of a randomized, open-label study in Latin American patients with rheumatoid arthritisMaria de la Vega, Generoso Guerra Bautista, Ricardo Machado Xavier, et al.
The Journal of Rheumatology|November 15, 2022
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV TrialFilip Van den Bosch, James Cheng-Chung Wei, Peter Nash, et al.
Rheumatology and Therapy|September 12, 2024
Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic ArthritisJelena Vojinović, Ivan Foeldvari, Joke Dehoorne, et al.
Pageof 2